Asunto(s)
Antineoplásicos/uso terapéutico , Infecciones por Coronavirus/prevención & control , Atención a la Salud/métodos , Neoplasias/tratamiento farmacológico , Pandemias/prevención & control , Neumonía Viral/prevención & control , Betacoronavirus , COVID-19 , Prueba de COVID-19 , China/epidemiología , Técnicas de Laboratorio Clínico , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Humanos , Control de Infecciones , Pulmón/diagnóstico por imagen , Tamizaje Masivo , Neoplasias/epidemiología , Seguridad del Paciente , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , SARS-CoV-2 , Tomografía Computarizada por Rayos XRESUMEN
We implement a logic switch by using a graphene acoustoelectric transducer at room temperature. We operate two pairs of inter-digital transducers (IDTs) to launch surface acoustic waves (SAWs) on a LiNbO3 substrate and utilize graphene as a channel material to sustain acoustoelectric current Iae induced by SAWs. By cooperatively tuning the input power on the IDTs, we can manipulate the propagation direction of Iae such that the measured Iae can be deliberately controlled to be positive, negative, or even zero. We define the zero-crossing Iae as [Formula: see text], and then demonstrate that Iae can be switched with a ratio [Formula: see text] at a rate up to few tens kHz. Our device with an accessible operation scheme provides a means to convert incoming acoustic waves modulated by digitized data sequence onto electric signals with frequency band suitable for digital audio modulation. Consequently, it could potentially open a route for developing graphene-based logic devices in large-scale integration electronics.
RESUMEN
Hepatocellular carcinoma (HCC) is a common cancer worldwide with a poor prognosis. Few strategies have been proven efficient in HCC treatment, particularly for those patients not indicated for curative resection or transplantation. Immunotherapy has been developed for decades for cancer control and is attaining more attention as a result of encouraging outcomes of new strategies such as chimeric antigen receptor T cells and immune checkpoint blockade. Right at the front of the new era of immunotherapy, we review the immunotherapy in HCC treatment, from basic research to clinical trials, covering anything from immunomodulators, tumor vaccines and adoptive immunotherapy. The mechanisms, efficacy and safety as well as the approach particulars are unveiled to assist readers to gain a concise but extensive understanding of immunotherapy of HCC.